Okomera’s cover photo
Okomera

Okomera

Biotechnology Research

Automated 3D organoid screening technology

About us

We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Paris
Type
Privately Held
Founded
2020

Locations

Employees at Okomera

Updates

  • Okomera reposted this

    View profile for Yannick Menel

    Country Manager Future4Care France - Digital Health Innovation

    🧐 When was the last time you had the chance to connect with 60 startups from all around the world? We’re just as thrilled as you are to be part of the next Future4Care Demo Day! 🚀 On March 13, the third edition of Europe’s largest healthtech hub kicks off—a full day dedicated to meeting and discovering the cutting-edge 🧬 innovations of Future4Care startups in life sciences and healthtech. (We heard you—last time was too short to make the most of all the connections! 😉) Come meet Hope Care, BioSerenity, ADLIN Science, Ziwig Biotech, Okomera, Healthy Mind, and 54 other startups, all gathered under one roof 🏢 at Future4care’s state-of-the-art facilities. 🔥 Don’t miss this unique opportunity! 🔥 👉 Registration : https://lnkd.in/evrXpSMB #Future4care #DemoDay2025 Capgemini Generali Orange Sanofi

  • Super proud to be recognized as one of the Top 22 TechBio startups in France in this new Mind Health study! 🇫🇷🔬 (Link in comments) 💡 A deep dive into how automation, engineering, AI combined with biology are transforming drug discovery—making it faster, more efficient, and bringing hope for more treatments addressing unmet medical needs. 📖 Read the study below! 👇

    • No alternative text description for this image
  • Okomera reposted this

    View profile for Sidarth Radjou

    CEO at Okomera | Drug Discovery with AI & Microfluidics powered organoid screening tech

    Super proud to be recognized as one of the Top 22 TechBio startups in France in this new Mind Health study! 🇫🇷🔬 (Link in comments) 💡 A deep dive into how automation, engineering, AI combined with biology are transforming drug discovery—making it faster, more efficient, and bringing hope for more treatments addressing unmet medical needs. 📖 Read the study below! 👇

    • No alternative text description for this image
  • View organization page for Okomera

    7,854 followers

    ✨ Excited to present our CRISPR Target validation platform work with our amazing team at AstraZeneca Simon Vyse and Dario De Felice at the World Organoid & Organ-on-a-Chip Research Day supported by ELRIG in Cambridge, UK!  Blessed to work with such enthusiastic, brilliant and fun scientists! 📌 Poster 19  : Enabling scalable CRISPR Screening in 3D Patient-derived organoids by using microfluidics-on-chip Thanks Miles R. for your wonderful welcome ! WORC.Community

    • No alternative text description for this image
  • Okomera reposted this

    View profile for Sidarth Radjou

    CEO at Okomera | Drug Discovery with AI & Microfluidics powered organoid screening tech

    🇫🇷🍷Our investor Berkeley SkyDeck in Paris for a founder's dinner in my favorite restaurant ! What an evening with Brian Bordley flying in from California to meet his portfolio companies in Paris ✈️ Inspiring to meet the founders of other companies in different batches : Okomera is Batch 15. Brian, on this photo, my bright smile is catched haha 📸SkyDeck applications are open - smartest, hungriest founders only apply here : https://lnkd.in/dPCvJVeE Anjuli Manche Tanel Petelot Nour Lake Hani Chalouati Koutheir Cherni Ghassen Menaouar

    • No alternative text description for this image
  • Okomera reposted this

    View profile for Sidarth Radjou

    CEO at Okomera | Drug Discovery with AI & Microfluidics powered organoid screening tech

    ✨ Proud to present 3 posters at the World Organoid & Organ-on-a-Chip Research Day supported by ELRIG! 🧫 Here are the first two: 📌 Poster 67 – Combinatorial Drug Screening on 3D Ewing Sarcoma Spheroids using Droplet-based Microfluidics 🔹 Showcasing our work with Curie Institute 📌 Poster 66 – End-to-End Automated Organoid Screening Platform: Application in Breast Cancer Drug Screening 🔹 Highlighting our collaboration with Gustave Roussy 👀 Come check them out & stay tuned for the 3rd poster! 🏆

    • No alternative text description for this image
  • 📰 US Press Release Alert - our scientist Lucile Mercier at SLAS 2025 presented breast cancer results from key collaboration with Gustave Roussy : Dr. Pierre Savagner, Principal Investigator at INSERM, Dr. Natacha Joyon, pathologist specializing in breast cancer, Dr. Barbara Pistilli, medical oncologist and head of the breast pathology committee, as well as Dr. Benjamin Verret, medical oncologist specializing in sarcomas and breast cancer. 🧫 The work from this collaboration demonstrates the capability of Okomera's platform to generate reproducible 3D organoids from patient-derived xenografts (PDX) and screen multiple drugs under various conditions. Read more here : https://lnkd.in/egGFiTjt

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Okomera 4 total rounds

Last Round

Grant

US$ 1.6M

Investors

Bpifrance
See more info on crunchbase